ATE472549T1 - Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel - Google Patents

Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel

Info

Publication number
ATE472549T1
ATE472549T1 AT07803370T AT07803370T ATE472549T1 AT E472549 T1 ATE472549 T1 AT E472549T1 AT 07803370 T AT07803370 T AT 07803370T AT 07803370 T AT07803370 T AT 07803370T AT E472549 T1 ATE472549 T1 AT E472549T1
Authority
AT
Austria
Prior art keywords
cupyrrol
derivatives
antiviral agents
antiviral
agents
Prior art date
Application number
AT07803370T
Other languages
English (en)
Inventor
Remy Lemoine
Chris Richard Melville
David Mark Rotstein
Jutta Wanner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38787632&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE472549(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE472549T1 publication Critical patent/ATE472549T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT07803370T 2006-09-18 2007-09-10 Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel ATE472549T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84533406P 2006-09-18 2006-09-18
PCT/EP2007/059453 WO2008034731A1 (en) 2006-09-18 2007-09-10 Octahydropyrrolo [3, 4-c] pyrrole derivatives an their use as antiviral agents

Publications (1)

Publication Number Publication Date
ATE472549T1 true ATE472549T1 (de) 2010-07-15

Family

ID=38787632

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07803370T ATE472549T1 (de) 2006-09-18 2007-09-10 Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel

Country Status (13)

Country Link
US (1) US7625905B2 (de)
EP (1) EP2066674B1 (de)
JP (1) JP2010503714A (de)
CN (1) CN101516884A (de)
AR (1) AR062798A1 (de)
AT (1) ATE472549T1 (de)
CA (1) CA2662835A1 (de)
CL (1) CL2007002671A1 (de)
DE (1) DE602007007497D1 (de)
ES (1) ES2345130T3 (de)
PE (1) PE20081375A1 (de)
TW (1) TW200821311A (de)
WO (1) WO2008034731A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011050200A1 (en) 2009-10-23 2011-04-28 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
WO2011050202A1 (en) 2009-10-23 2011-04-28 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
MX2012004753A (es) 2009-10-23 2012-09-07 Janssen Pharmaceutica Nv Octahidropirrolo[3,4-c]pirrolos disustituidos como moduladores del receptor de orexina.
US9586962B2 (en) 2011-04-20 2017-03-07 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
KR20140071318A (ko) 2011-06-19 2014-06-11 뉴욕 유니버시티 새로운 항-염증제 및 살균제로서의 류코톡신 e/d
SI3122750T1 (sl) 2014-03-26 2019-12-31 F. Hoffmann-La Roche Ag Biciklične spojine kot zaviralci proizvodnje avtotaksina (ATX) in lizofosfatidne kisline (LPA)
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環（４．５）癸烷衍生物
ES2686326T3 (es) 2014-07-15 2018-10-17 Grünenthal GmbH Derivados de azaspiro(4,5)decano sustituidos
JP6886967B2 (ja) 2015-09-04 2021-06-16 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ フェノキシメチル誘導体
RS63296B1 (sr) 2016-03-10 2022-07-29 Janssen Pharmaceutica Nv Metode lečenja depresije korišćenjem antagonista receptora oreksin-2
WO2018167113A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag New bicyclic compounds as atx inhibitors
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440803A1 (en) * 2001-03-07 2002-09-12 Pfizer Products Inc. Modulators of chemokine receptor activity
AU2003296992A1 (en) * 2002-12-13 2004-07-09 Smithkline Beecham Corporation Pyrrolidine and azetidine compounds as ccr5 antagonists
AU2003300902A1 (en) * 2002-12-13 2004-07-09 Smithkline Beecham Corporation Piperidine derivatives as CCR5 antagonists
CA2573951A1 (en) * 2003-07-18 2005-01-27 Virochem Pharma Inc. Spiro compounds and methods for the modulation of chemokine receptor activity
EP1654229B1 (de) 2003-07-31 2007-05-09 AstraZeneca AB Piperidinderivate als ccr5-rezeptormodulatoren
TW200610761A (en) * 2004-04-23 2006-04-01 Astrazeneca Ab Chemical compounds
PT1761542E (pt) 2004-06-09 2008-03-26 Hoffmann La Roche Derivados de octa-hidro-pirrolo[3,4-c) pirrole e o seu uso com agentes antivirais
SE0401657D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
SE0403106D0 (sv) 2004-12-20 2004-12-20 Astrazeneca Ab Chemical compounds
BRPI0710474A2 (pt) 2006-02-15 2011-08-16 Hoffmann La Roche compostos antivirais hetero bicìclicos
WO2007093515A1 (en) 2006-02-15 2007-08-23 F. Hoffmann La-Roche Ag Heterocyclic antiviral compounds

Also Published As

Publication number Publication date
JP2010503714A (ja) 2010-02-04
EP2066674A1 (de) 2009-06-10
EP2066674B1 (de) 2010-06-30
CL2007002671A1 (es) 2008-04-18
US20080103125A1 (en) 2008-05-01
ES2345130T3 (es) 2010-09-15
US7625905B2 (en) 2009-12-01
CA2662835A1 (en) 2008-03-27
TW200821311A (en) 2008-05-16
DE602007007497D1 (de) 2010-08-12
CN101516884A (zh) 2009-08-26
AR062798A1 (es) 2008-12-03
PE20081375A1 (es) 2008-10-17
WO2008034731A1 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
ATE472549T1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel
ATE543825T1 (de) Spiro-oxindolverbindungen und ihre verwendungen als therapeutische mittel
ATE543808T1 (de) 5,6-ring-annelierte indolderivate und ihre verwendung
ATE467633T1 (de) 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
ATE525374T1 (de) Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
EP2030974A4 (de) Heterozyklische nichtnukleosidverbindungen, ihre herstellung, pharmazeutische zusammensetzung und ihre verwendung als antivirale mittel
DE602005013491D1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
ATE514695T1 (de) Pyrido(2,3-d)pyrimidinonverbindungen und ihre verwendung als pi3-inhibitoren
ATE509016T1 (de) 2-aryl-5-heterocyclylcyclohexan-1,3- dionverbindungen und ihre verwendung als herbizide
DE602005004144D1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und deren verwendung als antivirale mitteln
ATE531712T1 (de) Substituierte aryloxazole und ihre verwendung
DE602007013869D1 (de) Substituierte imidazole und ihre verwendung als pestizide
ATE440093T1 (de) 1-alkinyl-2-aryloxyalkylamide und ihre verwendung als fungizide
ATE478059T1 (de) Cinnamoylpiperazinderivate und ihre verwendung als par-1-antagonisten
DE602006013878D1 (de) Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
DE602007009205D1 (de) Pyrrolochinoxalinonderivate als antibakterielle mittel
ATE486076T1 (de) 6-carboxy-normorphinan-derivate, ihre synthese und verwendung
ATE544752T1 (de) Aryloxyacetamidderivate und ihre verwendung als fungizide
ATE454377T1 (de) 2-phenyl-6-aminocarbonylpyrimidinderivate und ihre verwendung als antagonisten am p2y12- rezeptor
ATE470667T1 (de) Neue benzothiazinonderivate und ihre verwendung als antibakterielle mittel
DE602006018143D1 (de) (6-FLU0R-BENZ0Äl, 3ÜDIOXOLYL)-MORPHOLIN-4-YL-METHANONE UND DEREN VERWENDUNG ALS CBl-LIGANDEN
ATE471938T1 (de) Substituierte diazaspiroä4.5üdecanderivate und deren verwendung als neurokininantagonisten
ATE513817T1 (de) Pyrimidinderivate und ihre verwendung als pestizide
ATE442366T1 (de) Oxazolidinonderivate und ihre verwendung als antibiotika
ATE520654T1 (de) Polypyrrol-derivate, ihre herstellung und ihre therapeutische verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2066674

Country of ref document: EP